SeaStar Medical is trading 6.1% up now at $3.48 after opening-market gains, with upcoming events possibly supporting investor interest, though no direct causal link is confirmed.
- No new company-specific announcement dated August 10, 2026, has been identified.
- Second-quarter results are scheduled after market close on August 12, 2026.
- An acute kidney injury webinar is scheduled for August 11, 2026.